Skip to main content
Otgonjargal Byambaa on Muck Rack

Otgonjargal Byambaa

As seen in: Wiley Online Library, PLOS ONE, The Lancet, ASM Journals
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Otgonjargal

Contact Otgonjargal, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

In vitro selection and characterization of resistance to pristinamycin in Mycoplasma genitalium

|
By Otgonjargal Byambaa, Chloé Le Roy, Jennifer Guiraud
| ASM Journals
INTRODUCTION Mycoplasma genitalium is a recognized sexually transmitted organism associated with 15%–25% cases of non-gonococcal urethritis in men (1). In women, it is linked to cervicitis and pelvic inflammatory disease. Only a few antimicrobial classes are active against M. genitalium, including macrolides, fluoroquinolones, tetracyclines, and streptogramin combinations (2).
Open in Who Shared Issue with article?

Molecular epidemiology of SARS‐CoV‐2 in Mongolia, first experience with nanopore sequencing in lower‐ and middle‐income countries setting

|
By Otgonjargal Byambaa, Munkhtuya Erendereg, Suvd Tumurbaatar, Gerelmaa Enebish
| Wiley Online Library Verified
1 INTRODUCTION Coronavirus disease (COVID-19) has had a profound impact on the world since its emergence in December 2019.1, 2 The rapid spread of the virus across the globe prompted an urgent need for research into its epidemiology and transmission patterns, particularly for the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants which had strong impacts on its transmissibility and disease severity.3, 4 Whole genome sequencing is an essential part of molecular...
Open in Who Shared Issue with article?

RBD-specific antibody response after two doses of different SARS-CoV-2 vaccines during the mass vaccination campaign in Mongolia

|
By Ganbaatar Byambatsogt, Otgonjargal Byambaa, Burenjargal Batmunkh, Dashpagma Otgonbayar
| PLOS ONE
Citation: Batmunkh B, Otgonbayar D, Shaarii S, Khaidav N, Shagdarsuren O-E, Boldbaatar G, et al. (2023) RBD-specific antibody response after two doses of different SARS-CoV-2 vaccines during the mass vaccination campaign in Mongolia. PLoS ONE 18(12): e0295167.
Open in Who Shared Issue with article?
See all 4 articles